Page last updated: 2024-08-22

deuterium and Dyslipidemias

deuterium has been researched along with Dyslipidemias in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bateman, K; Chan, CC; Huang, Z; Landry, F; Leclair, G; Li, CS; Oballa, R; Zhang, L1
Adiels, M; Borén, J; Caslake, MJ; Olofsson, SO; Packard, C; Soro, A; Stewart, P; Taskinen, MR; Wennberg, B; Westerbacka, J1

Trials

1 trial(s) available for deuterium and Dyslipidemias

ArticleYear
Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia.
    Arteriosclerosis, thrombosis, and vascular biology, 2005, Volume: 25, Issue:8

    Topics: Adult; Apolipoproteins B; Blood Glucose; Cholesterol, HDL; Cholesterol, VLDL; Deuterium; Diabetes Mellitus, Type 2; Dyslipidemias; Glycerol; Humans; Hyperglycemia; Insulin Resistance; Leucine; Male; Triglycerides

2005

Other Studies

1 other study(ies) available for deuterium and Dyslipidemias

ArticleYear
Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors.
    Journal of lipid research, 2011, Volume: 52, Issue:8

    Topics: Acetates; Animals; Biological Assay; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Deuterium; Diabetes Mellitus; Dyslipidemias; Enzyme Inhibitors; Humans; Liver; Male; Mass Spectrometry; Molecular Targeted Therapy; Oleic Acid; Plasma; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase; Tetrazoles

2011